P01.041 Secondary prophylaxis with romiplostim for temozolomide-induced thrombocytopenia in newly diagnosed glioblastoma

BACKGROUND: Thrombocytopenia is a major adverse event of temozolomide (TMZ) chemotherapy. It may lead to dose reduction/interruption or bleeding. Platum (NCT02227576) was a phase II open label, multicenter single arm trial evaluating the thrombopoetin receptor agonist, romiplostim, for secondary pre...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Neuro Oncol
मुख्य लेखकों: Le Rhun, E, Devos, P, Houillier, C, Cartalat-Carel, S, Chinot, O, Di Stefano, A, Reyns, N, Dubois, F, Weller, M
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Oxford University Press 2018
विषय:
Poster Presentations
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6144386/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.083
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन